Article Text

PDF
THU0065 Cytokines and lipocalin-2 in pregnant women with rheumatoid arthritis and systemic lupus erythematosus
  1. TT Pedersen1,
  2. MH Fenstad2,
  3. TS Moksnes1,
  4. M Wallenius1,
  5. TH Flo3,
  6. M Haug3
  1. 1Norwegian National Advisory Unit on Pregnancy and Rheumatic diseases
  2. 2Dep. of Immunology and Transfusion Medicine, St. Olavs Hospital
  3. 3Centre of Molecular Inflammation Research and Dep. of Cancer Research and Molecular Medicine, NTNU, Trondheim, Norway

Abstract

Background Rheumatoid arthritis (RA), and especially seronegative RA, is often ameliorated by pregnancy, while systemic lupus erythematosus (SLE) is prone to flare and associated with pregnancy complications. Cytokines and chemokines are of great importance for immune processes during pregnancy. The inflammatory marker Lipocalin-2 (LCN2) has become increasingly relevant as a potential clinical biomarker of rheumatic diseases (1). LCN2 is produced in the maternal-fetal interface during normal pregnancies and correlates with the presence and severity of preeclampsia (2).

Objectives To obtain a better understanding of immune regulation and the disparate immune responses in pregnant women with RA and SLE. In this pilot study, we analyzed levels of multiple cytokines, chemokines and LCN2 in women with seropositive RA, seronegative RA, SLE and healthy controls during pregnancy and postpartum.

Methods The Norwegian National Advisory Unit on Pregnancy and Rheumatic Diseases collect serum samples in a biobank from women with inflammatory rheumatic diseases before pregnancy, during pregnancy week 10–12, week 23–25, week 30–32 and 6 weeks, 6 months and 12 months postpartum. Control serum samples were collected from healthy pregnant women at matching time-points. We analyzed serum cytokine and chemokine levels using a multiplex assay. A sandwich ELISA was used to measure LCN2. In this pilot study we included pregnant women with SLE (n=4), seropositive RA (n=4), seronegative RA (n=2) and healthy pregnant controls (n=4). The total cohort consists so far of 18 pregnant women with SLE and 23 pregnant women with RA.

Results We observed lower LCN2 levels during pregnancy in SLE patients, compared to controls and RA patients. LCN2 levels in seropositive RA patients and controls were found to be comparable during pregnancy, whereas pregnant women with seronegative RA showed higher LCN2 levels. Levels of IFNγ, IL-6 and IP-10 were higher in SLE than in RA patients during the course of pregnancy. IL-17 was slightly higher only in seropositive RA patients compared to controls. TNFα was slightly higher in both SLE and RA patients compared to controls, levels of anti-inflammatory IL-10 were very low or undetectable in all groups.

Conclusions We found interesting differences in cytokine, chemokine and LCN2 levels during pregnancy in women with SLE, seropositive RA and seronegative RA. The results need confirmation in the total cohort and will be further explored for a better understanding of the disparate immune modulation of RA and SLE during pregnancy.

References

  1. Abella V et al. Biomarkers. 2015;20(8):565–71.

  2. Kim SM et al. Reproductive sciences. 2013;20(9):1083–9.

References

Acknowledgements This study is supported by grants from St. Olavs Hospital and Norsk Revmatikerforbund.

Disclosure of Interest None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.